Singular Genomics Systems Inc reports results for the quarter ended in June - Earnings Summary

Singular Genomics Systems

03/08/2021 12:14

* Singular Genomics Systems Inc  OMIC.OQ  reported a quarterly
adjusted loss of 43 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 20 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Singular Genomics Systems Inc's reported EPS for the quarter
was a loss of $1.18​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Singular Genomics Systems Inc shares had fallen by 33.6% this
quarter.
* The company reported a quarterly loss of $37.48 million.
* Wall Street's median 12-month price target for Singular
Genomics Systems Inc is $35.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 3 at 11:14 a.m.  ​All
figures in US dollars unless otherwise stated